Targeting the mTOR Pathway in Leukemia von Dinner, Shira, Platanias, Leonidas C.

Volltext

Dosing of 7 + 3 induction chemotherapy in a patient with acute myeloid leukemia (AML) and morbid obesity von Franco, Stephanie, Khan, Talha, Dinner, Shira, Karmali, Reem, Melody, Megan

Volltext

Future health of AYA survivors von Burkart, Madelyn, Sanford, Stacy, Dinner, Shira, Sharp, Lisa, Kinahan, Karen

Volltext

Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial von Watts, Justin M, Baer, Maria R, Yang, Jay, Prebet, Thomas, Lee, Sangmin, Schiller, Gary J, Dinner, Shira N, Pigneux, Arnaud, Montesinos, Pau, Wang, Eunice S, Seiter, Karen P, Wei, Andrew H, De Botton, Stephane, Arnan, Montserrat, Donnellan, Will, Schwarer, Anthony P, Récher, Christian, Jonas, Brian A, Ferrell, P Brent, Marzac, Christophe, Kelly, Patrick, Sweeney, Jennifer, Forsyth, Sanjeev, Guichard, Sylvie M, Brevard, Julie, Henrick, Patrick, Mohamed, Hesham, Cortes, Jorge E

Volltext

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults von Litzow, Mark R., Sun, Zhuoxin, Mattison, Ryan J., Paietta, Elisabeth M., Roberts, Kathryn G., Zhang, Yanming, Racevskis, Janis, Lazarus, Hillard M., Rowe, Jacob M., Arber, Daniel A., Wieduwilt, Matthew J., Liedtke, Michaela, Bergeron, Julie, Wood, Brent L., Zhao, Yaqi, Wu, Gang, Chang, Ti-Cheng, Zhang, Wenchao, Pratz, Keith W., Dinner, Shira N., Frey, Noelle, Gore, Steven D., Bhatnagar, Bhavana, Atallah, Ehab L., Uy, Geoffrey L., Jeyakumar, Deepa, Lin, Tara L., Willman, Cheryl L., DeAngelo, Daniel J., Patel, Shejal B., Elliott, Michelle A., Advani, Anjali S., Tzachanis, Dimitrios, Vachhani, Pankit, Bhave, Rupali R., Sharon, Elad, Little, Richard F., Erba, Harry P., Stone, Richard M., Luger, Selina M., Mullighan, Charles G., Tallman, Martin S.

Volltext

Epistaxis, Ecchymoses, and an Abnormal White Blood Cell Count von Sellers, Meredith H, Dinner, Shira N

Volltext

Therapy-related B-cell acute lymphoblastic leukemia in adults has unique genetic profile with frequent loss of TP53 and inferior outcome von Barnea Slonim, Liron, Gao, Juehua, Burkart, Madelyn, Odetola, Oluwatobi E., Kocherginsky, Masha, Dinner, Shira N., Lu, Xinyan, Wehbe, Firas, Jennings, Lawrence, Altman, Jessica K., Mirza, Kamran M., Chen, Yi-Hua, Sukhanova, Madina

Volltext

Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemi... von Badar, Talha, Szabo, Aniko, Litzow, Mark, Burkart, Madelyn, Yurkiewicz, Ilana, Dinner, Shira, Hefazi, Mehrdad, Shallis, Rory M., Podoltsev, Nikolai, Patel, Anand A., Curran, Emily, Wadleigh, Martha, Balasubramanian, Suresh, Yang, Jay, Arslan, Shukaib, Aldoss, Ibrahim, Mattison, Ryan, Cenin, Danielle, Siebenaller, Caitlin, Advani, Anjali, Liedtke, Michaela, Atallah, Ehab

Volltext

Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement von Dinner, Shira, Witteles, Wesley, Afghahi, Anosheh, Witteles, Ronald, Arai, Sally, Lafayette, Richard, Schrier, Stanley L, Liedtke, Michaela

Volltext

Moxetumomab pasudotox for hairy cell leukemia: preclinical development to FDA approval von Lin, Adam Yuh, Dinner, Shira Naomi

Volltext

Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia von Burkart, Madelyn, Dinner, Shira

Volltext

Fatigue and an Elevated White Blood Cell Count von Sellers, Meredith H, Dinner, Shira N

Volltext

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG... von Palmisiano, Neil D., Lee, Ju‐Whei, Claxton, David F., Paietta, Elisabeth M., Alkhateeb, Hassan, Park, Jae, Podoltsev, Nikolai A., Atallah, Ehab L., Schaar, Dale G., Dinner, Shira N., Webster, Jonathan A., Luger, Selina M., Litzow, Mark R.

Volltext

P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) von Burkart, Madelyn, Khan, Talha, Dinner, Shira, Frankfurt, Olga, Altman, Jessica, Abaza, Yasmin

Volltext

Antibody-based therapies in patients with acute lymphoblastic leukemia von Dinner, Shira, Liedtke, Michaela

Volltext

New strategies for relapsed acute myeloid leukemia: fertile ground for translational research von Dinner, Shira N, Giles, Francis J, Altman, Jessica K

Volltext

The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis von Dinner, Shira, Witteles, Wesley, Witteles, Ronald, Lam, Anthony, Arai, Sally, Lafayette, Richard, George, Tracy I., Schrier, Stanley L., Liedtke, Michaela

Volltext

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies von Davids, Matthew S, Brander, Danielle M, Alvarado Valero, Yesid, Diefenbach, Catherine Sibyl, Egan, Daniel Nathan, Dinner, Shira Naomi, Javidi-Sharifi, Nathalie, Al Malki, Monzr M, Begna, Kebede, Bhatt, Vijaya R, Abedin, Sameem, Cook, Rachel, Collins, Mary C, Roleder, Carly, Dominguez, Edward C, Rajagopalan, Prabhu, Wiley, Sandra E, Ghalie, Richard G, Danilov, Alexey V

Volltext

Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia von Waisbren, Julie, Dinner, Shira, Altman, Jessica, Frankfurt, Olga, Helenowski, Irena, Gao, Juehua, McMahon, Brandon J., Stein, Brady L.

Volltext

S117: CHEMOTHERAPY‐FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY‐DIAGNOSED, PH‐NEGATIVE, CD22‐POSITIVE, B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA... von Wieduwilt, Matthew, Yin, Jun, Kour, Oudom, Teske, Rebecca, Stock, Wendy, Byrd, Ken, Doucette, Kimberly, Mangan, James, Masters, Gregory, Mims, Alice, Jamieson, Katarzyna, Dinner, Shira, Bseiso, Ali, Uy, Geoffrey, Erba, Harry, Litzow, Mark, Stone, Richard

Volltext